Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Locker

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Critical Care Medicine|June 2, 2000
Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unitT Staudinger, B Stoiser, M Müllner, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 2, 2004
Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosageB Meyer, F Traunmüller, A Hamwi, et al.
Cancer Immunology, Immunotherapy : CII|September 22, 2000
Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial. Austrian Renal Cell Carcinoma Study GroupM Schmidinger, G G Steger, C Wenzel, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1999
Continuous infusion versus intermittent administration of meropenem in critically ill patientsF Thalhammer, F Traunmüller, I El Menyawi, et al.
The Journal of Trauma|March 1, 1997
Prostaglandin E1 inhibits platelet decrease after massive blood transfusions during major surgery: influence on coagulation cascade?G J Locker, T Staudinger, S Knapp, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2005
Fulvestrant ('Faslodex') in pre-treated patients with advanced breast cancer: a single-centre experienceG G Steger, R Bartsch, C Wenzel, et al.
Wiener Klinische Wochenschrift|September 29, 2000
Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancerM Schmidinger, A C Budinsky, C Wenzel, et al.
Wiener Klinische Wochenschrift|December 31, 1997
Renal tolerability of four different once-daily dose regimen of netilmicin in critical care patientsK Laczika, T Staudinger, U Hollenstein, et al.
Intensive Care Medicine|September 1, 1996
Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shockT Staudinger, E Presterl, W Graninger, et al.
Clinical Immunology and Immunopathology|September 1, 1996
Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsisH Burgmann, S Winkler, G J Locker, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Critical Care Medicine|June 2, 2000
Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unitT Staudinger, B Stoiser, M Müllner, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 2, 2004
Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosageB Meyer, F Traunmüller, A Hamwi, et al.
Cancer Immunology, Immunotherapy : CII|September 22, 2000
Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial. Austrian Renal Cell Carcinoma Study GroupM Schmidinger, G G Steger, C Wenzel, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1999
Continuous infusion versus intermittent administration of meropenem in critically ill patientsF Thalhammer, F Traunmüller, I El Menyawi, et al.
The Journal of Trauma|March 1, 1997
Prostaglandin E1 inhibits platelet decrease after massive blood transfusions during major surgery: influence on coagulation cascade?G J Locker, T Staudinger, S Knapp, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2005
Fulvestrant ('Faslodex') in pre-treated patients with advanced breast cancer: a single-centre experienceG G Steger, R Bartsch, C Wenzel, et al.
Wiener Klinische Wochenschrift|September 29, 2000
Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancerM Schmidinger, A C Budinsky, C Wenzel, et al.
Wiener Klinische Wochenschrift|December 31, 1997
Renal tolerability of four different once-daily dose regimen of netilmicin in critical care patientsK Laczika, T Staudinger, U Hollenstein, et al.
Intensive Care Medicine|September 1, 1996
Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shockT Staudinger, E Presterl, W Graninger, et al.
Clinical Immunology and Immunopathology|September 1, 1996
Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsisH Burgmann, S Winkler, G J Locker, et al.
Pageof 6